Paola Patrignani
Chieti, 66100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
FBiosynthesis and analytics of specialized pro-resolving mediators: facts and faults.
Journal: Journal of lipid research
Published: June 24, 2026
The crucial role of thromboxane A2 in colorectal cancer development and metastasis: a key target for anticancer therapy.
Journal: Frontiers in pharmacology
Published: January 14, 2026
Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor Antagonists.
Journal: Journal of medicinal chemistry
Published: October 22, 2025
GY971 mitigates inflammation by reducing neutrophil recruitment in cystic fibrosis Ex Vivo and In Vivo models.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: September 24, 2025
Response to correspondence: "Janus kinase inhibitors enhance prostanoid biosynthesis in human whole blood in vitro: implications for cardiovascular side effects and prevention strategies".
Journal: Annals of the rheumatic diseases
Published: June 05, 2025
Editorial: Inflammation and lipid signaling in disease pathogenesis.
Journal: Frontiers in pharmacology
Published: May 06, 2025
Platelet activation, aspirin, and cancer: From basic science to clinical trials.
Journal: Pharmacological reviews
Published: April 29, 2025
Janus kinase inhibitors enhance prostanoid biosynthesis in human whole blood in vitro: implications for cardiovascular side effects and prevention strategies.
Journal: Annals of the rheumatic diseases
Published: November 28, 2024
Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention.
Journal: Frontiers in pharmacology
Published: October 31, 2024
Evaluating plasma vesicle signatures in chronic coronary artery disease patients for tailored dual therapy with low-dose rivaroxaban and aspirin.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 18, 2024
New antiplatelet approach: inhibiting Pim kinase to reduce constitutive surface expression of thromboxane A2 receptor.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 11, 2024
Last Updated: 09/26/2026